Question 1

What are the potential benefits of participating in this trial compared to standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients clinical trial (NCT03053856). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from pembrolizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients clinical trial (NCT03053856). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients clinical trial (NCT03053856). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my cancer comes back during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients clinical trial (NCT03053856). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I need to provide tissue samples, and what will they be used for?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients clinical trial (NCT03053856). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients clinical trial (NCT03053856). Contact the study team or your healthcare provider for specific answers.

What this study is about